Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.09 | 0.09 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.085 | 0.09 |